AAAAAA

   
Results: 1-14 |
Results: 14

Authors: Chirikos, TN Ruckdeschel, JC Krischer, JP
Citation: Tn. Chirikos et al., Impact of clinical trials on the cost of cancer care, MED CARE, 39(4), 2001, pp. 373-383

Authors: Chase, HP Cuthbertson, DD Dolan, LM Kaufman, F Krischer, JP Schatz, DA White, NH Wilson, DM Wolfsdorf, J
Citation: Hp. Chase et al., First-phase insulin release during the intravenous glucose tolerance test as a risk factor for type 1 diabetes, J PEDIAT, 138(2), 2001, pp. 244-249

Authors: Zeidler, A Raffel, LJ Costin, G Shaw, SJ Buchanan, TA Noble, J Rotter, JI Palmer, J Krischer, JP Wait, C Maclaren, NK
Citation: A. Zeidler et al., Autoantibodies and human leucocyte antigen class II in first-degree familymembers of Mexican-American type 1 diabetic patients, J CLIN END, 86(10), 2001, pp. 4957-4962

Authors: Yu, LP Cuthbertson, DD Maclaren, N Jackson, R Palmer, JP Orban, T Eisenbarth, GS Krischer, JP
Citation: Lp. Yu et al., Expression of GAD65 and islet cell antibody (ICA512) autoantibodies among cytoplasmic ICA+ relatives is associated with eligibility for the Diabetes Prevention Trial Type 1, DIABETES, 50(8), 2001, pp. 1735-1740

Authors: Greenbaum, CJ Cuthbertson, D Krischer, JP
Citation: Cj. Greenbaum et al., Type 1 diabetes manifested solely by 2-h oral glucose tolerance test criteria, DIABETES, 50(2), 2001, pp. 470-476

Authors: Mulne, AF Ducore, JM Elterman, RD Friedman, HS Krischer, JP Kun, LE Shuster, JJ Kadota, RP
Citation: Af. Mulne et al., Oral methotrexate for recurrent brain tumors in children: A Pediatric Oncology Group Study, J PED H ONC, 22(1), 2000, pp. 41-44

Authors: Roetzheim, RG Pal, N Van Durme, DJ Wathington, D Ferrante, JM Gonzalez, EC Krischer, JP
Citation: Rg. Roetzheim et al., Increasing supplies of dermatologists and family physicians are associatedwith earlier stage of melanoma detection, J AM ACAD D, 43(2), 2000, pp. 211-218

Authors: Roetzheim, RG Pal, N Gonzalez, EC Ferrante, JM Van Durme, DJ Krischer, JP
Citation: Rg. Roetzheim et al., Effects of health insurance and race on colorectal cancer treatments and outcomes, AM J PUB HE, 90(11), 2000, pp. 1746-1754

Authors: Greenbaum, CJ Schatz, DK Cuthbertson, D Zeidler, A Eisenbarth, GS Krischer, JP
Citation: Cj. Greenbaum et al., Islet cell antibody-positive relatives with human leukocyte antigen DQA10102, DQB1*0602: Identification by the diabetes prevention trial-type 1, J CLIN END, 85(3), 2000, pp. 1255-1260

Authors: Rosenbloom, AL Schatz, DA Krischer, JP Skyler, JS Becker, DJ Laporte, RE Libman, I Pietropaolo, M Dosch, HM Finberg, L Muir, A Tamborlane, WV Grey, M Silverstein, JH Malone, JI
Citation: Al. Rosenbloom et al., Prevention and treatment of diabetes in children, J CLIN END, 85(2), 2000, pp. 494-495

Authors: Roetzheim, RG Gonzalez, EC Ferrante, JM Pal, N Van Durme, DJ Krischer, JP
Citation: Rg. Roetzheim et al., Effects of health insurance and race on breast carcinoma treatments and outcomes, CANCER, 89(11), 2000, pp. 2202-2213

Authors: Roetzheim, RG Pal, N Tennant, C Voti, L Ayanian, JZ Schwabe, A Krischer, JP
Citation: Rg. Roetzheim et al., Effects of health insurance and race on early detection of cancer, J NAT CANC, 91(16), 1999, pp. 1409-1415

Authors: Kung, FH Harris, MB Krischer, JP
Citation: Fh. Kung et al., Ifosfamide/Carboplatin/Etoposide (ICE), an effective salvaging therapy forrecurrent malignant non-Hodgkin lymphoma of childhood: A pediatric oncology group phase II study, MED PED ONC, 32(3), 1999, pp. 225-226

Authors: Roetzheim, RG Pal, N Gonzalez, EC Ferrante, JM Van Durme, DJ Ayanian, JZ Krischer, JP
Citation: Rg. Roetzheim et al., The effects of physician supply on the early detection of colorectal cancer, J FAM PRACT, 48(11), 1999, pp. 850-858
Risultati: 1-14 |